CytomX Therapeutics Inc (CTMX)
4.455
-0.03
(-0.76%)
USD |
NASDAQ |
May 03, 16:00
4.69
+0.24
(+5.27%)
After-Hours: 20:00
CytomX Therapeutics Accounts Payable (Quarterly): 1.458M for Dec. 31, 2023
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 1.458M |
September 30, 2023 | 1.705M |
June 30, 2023 | 1.029M |
March 31, 2023 | 2.203M |
December 31, 2022 | 2.809M |
September 30, 2022 | 5.176M |
June 30, 2022 | 1.92M |
March 31, 2022 | 1.721M |
December 31, 2021 | 2.818M |
September 30, 2021 | 1.516M |
June 30, 2021 | 1.755M |
March 31, 2021 | 2.582M |
December 31, 2020 | 2.996M |
September 30, 2020 | 3.643M |
June 30, 2020 | 4.927M |
March 31, 2020 | 3.782M |
December 31, 2019 | 4.158M |
September 30, 2019 | 4.55M |
Date | Value |
---|---|
June 30, 2019 | 4.52M |
March 31, 2019 | 9.511M |
December 31, 2018 | 5.132M |
September 30, 2018 | 6.871M |
June 30, 2018 | 4.24M |
March 31, 2018 | 5.349M |
December 31, 2017 | 4.205M |
September 30, 2017 | 2.869M |
June 30, 2017 | 6.364M |
March 31, 2017 | 3.70M |
December 31, 2016 | 6.596M |
September 30, 2016 | 0.517M |
June 30, 2016 | 1.426M |
March 31, 2016 | 4.958M |
December 31, 2015 | 4.697M |
September 30, 2015 | 2.70M |
June 30, 2015 | 0.76M |
December 31, 2014 | 1.919M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
1.029M
Minimum
Jun 2023
5.176M
Maximum
Sep 2022
2.909M
Average
2.809M
Median
Dec 2022
Accounts Payable (Quarterly) Benchmarks
Ocular Therapeutix Inc | 4.389M |
Bristol-Myers Squibb Co | 3.539B |
ACADIA Pharmaceuticals Inc | 17.54M |
Cytokinetics Inc | 21.51M |
Calidi Biotherapeutics Inc | 2.877M |